Skip to main content

Table 1 Clinical characteristics of treatment-naive patients with EHI sample and HCs

From: Reduced eIF3d accelerates HIV disease progression by attenuating CD8+ T cell function

Characteristic Rapid progressors Chronic progressors Healthy controls
N 8 7 11
Han ethnic, no. (%) 8 (100) 7 (100) 11 (100)
Age (years, mean ± SD) 35.88 ± 10.6 28.57 ± 13.99 30.5 ± 8.84
Male (No. %) 8 (100) 7 (100) 11 (100)
CD4 (cells/μl, mean ± SD) 266.5 ± 45.49 630.29 ± 116.9  
VL (log copies/ml, mean ± SD) 4.75 ± 0.72 3.54 ± 0.78  
Sample day (day, mean ± SD) 99.63 ± 28.04 94.71 ± 14.23  
  1. VL viral load